Pharmacokinetic scaling of bisphenol A by species-invariant time methods

被引:21
作者
Cho, CY
Shin, BS
Jung, JH
Kim, DH
Lee, KC
Han, SY
Kim, HS
Lee, BM
Yoo, SD
机构
[1] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea
[2] Natl Inst Toxicol Res, Div Reprod & Dev Toxicol, Seoul 122704, South Korea
关键词
D O I
10.1080/00498250210163315
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The study was performed to predict the pharmacokinetic disposition of bisphenol A in humans using simple allometry and several species-invariant time methods based on animal data. Bisphenol A was injected intravenously to mouse, rat, rabbit and dog (1-2 mg kg(-1) doses). 2. The obtained serum concentration-time profiles were best described by biexponential equations in all these animal species, with the mean Cl, V-ss and t(1/2) Of 0.31 h(-1), 0.1 litres and 39.9 min in mouse, 1.91 h(-1), 1.3 litres and 37.6 min in rat, 12.6 1 h(-1), 7.1 litres and 40.8 min in rabbit, and 27.11 h(-1), 20.0 litres and 43.7 min in dog, respectively. 3. The human pharmacokinetic parameters of Cl, V-ss and t(1/2) were predicted by simple allometry as well as by normalization according to species-invariant times of kallynochrons, apolysichrons and dienctichrons. 4. The simple allometric scaling and different time transformation methods predicted the human Cl, V-ss and t(1/2) ranging from 46.0 to 127.11 h(-1), 125.3 to 229.7 litres and 43.6 to 196.2 min, respectively. Species - invariant time transformations showed that all animal data from the four species were superimposable. These preliminary parameter values may be useful in interpreting toxicity data in humans on environmental exposure to bisphenol A.
引用
收藏
页码:925 / 934
页数:10
相关论文
共 25 条
[1]   INTERSPECIES PHARMACOKINETIC SCALING AND THE EVOLUTIONARY-COMPARATIVE PARADIGM [J].
BOXENBAUM, H .
DRUG METABOLISM REVIEWS, 1984, 15 (5-6) :1071-1121
[2]  
BOXENBAUM H, 1983, AM J PHYSIOL, V245, P768
[3]   Profound effects of the weak environmental estrogen-like chemical bisphenol A on the growth of the mammary gland of noble rats [J].
Colerangle, JB ;
Roy, D .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 60 (1-2) :153-160
[4]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[5]   ANIMAL SCALE-UP [J].
DEDRICK, RL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (05) :435-460
[6]   Effect of neonatal exposure to estrogenic compounds on development of the excurrent ducts of the rat testis through puberty to adulthood [J].
Fisher, JS ;
Turner, KJ ;
Brown, D ;
Sharpe, RM .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 (05) :397-405
[7]   INTERSPECIES SCALING AND COMPARISONS IN DRUG DEVELOPMENT AND TOXICOKINETICS [J].
INGS, RMJ .
XENOBIOTICA, 1990, 20 (11) :1201-1231
[8]  
KEITH LH, 1997, ENV ENDOCRINE DISRUP, P261
[9]   BISPHENOL-A - AN ESTROGENIC SUBSTANCE IS RELEASED FROM POLYCARBONATE FLASKS DURING AUTOCLAVING [J].
KRISHNAN, AV ;
STATHIS, P ;
PERMUTH, SF ;
TOKES, L ;
FELDMAN, D .
ENDOCRINOLOGY, 1993, 132 (06) :2279-2286
[10]  
McNamara P. J., 1991, PHARM BIOEQUIVALENCE, P267